Articles
-
3 days ago |
today.westlaw.com | Anton Bridge |Aurora Ellis |Mohammed Shamsi |Roushni Nair
(Reuters) -Nomura is acquiring Macquarie Group's U.S. and European public asset management businesses for $1.8 billion, marking the Japanese investment bank's most ambitious expansion abroad since its failed purchase of Lehman Brothers' assets....
-
1 week ago |
today.westlaw.com | Patrick Wingrove |Mohammed Shamsi |Savyata Mishra |Kamal Choudhury
(Reuters) -U.S. Food and Drug Administration Commissioner Martin Makary announced on Thursday a policy to limit employees of companies regulated by the agency, such as pharmaceutical firms, from serving as official members on FDA's advisory...
-
1 week ago |
today.westlaw.com | Emma-Victoria Farr |Janaki Venugopalan |Mohammed Shamsi |Joe Bavier
FRANKFURT (Reuters) -U.S.-based private equity firm KKR has reached a deal with Frankfurt-listed Datagroup to buy the firm in an all-cash transaction that values it at about 450 million euros ($508 million), the IT services provider said on Tuesday....
-
1 month ago |
today.westlaw.com | Mohammed Shamsi |Harshita Mary Varghese
(Reuters) - Yahoo has signed a deal to sell its 20-year-old technology news website, TechCrunch, to media investment firm Regent, the companies said on Friday.
-
1 month ago |
today.westlaw.com | Mohammed Shamsi |Sneha K
(Reuters) - Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. Pemvidutide belongs to the same class of...
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →